News | August 28, 2008

First Cancer Patients Treated With Monaco Radiation Treatment Planning System

August 29, 2008 - CMS Inc., an Elekta Co., reported today that three sites have delivered clinical treatments utilizing its Monaco next-generation intensity modulated radiotherapy (IMRT) treatment planning system.

Allegheny General Hospital (Pittsburgh, PA), Erasmus Medical Center (Rotterdam, Netherlands) and Froedtert Memorial Lutheran Hospital (Milwaukee, WI) have all begun producing treatment plans with the application.

Monaco reportedly represents a fundamentally new approach to IMRT planning featuring biological modeling, constrained optimization and Monte Carlo dose calculation algorithms, and includes a unique and sophisticated set of tools to make the radiotherapy planning process easier, more straightforward and clinically reliable.

"The biologically-based Monaco IMRT treatment planning system produces clinically relevant plans, which are dosimetrically superior to plans from dose-based IMRT treatment planning systems, feature shorter plan delivery times, and can be easily verified with normal QA procedures," said Moyed Miften, Ph.D., DABR, and Allegheny General Hospital's chief of medical physics. "The multi-criteria optimization and the sensitivity analysis tools in the Monaco system also help reduce the time needed to optimize IMRT plans."

Monaco’s features, designed to improve IMRT planning, include:
- Sensitivity Analysis tool that minimizes trial-and-error by guiding the decision-making process

- Smart Sequencing, a constrained aperture optimization that produces efficient step-and-shoot segments

- Biological models, voxel definition controls and multi-criterial goals that provide more intuitive and direct control over the optimization process

For more information: www.cmsrtp.com, www.elekta.com

Related Content

Hypofractionated Radiation Provides Same Prostate Cancer Outcomes as Conventional Radiation
News | Intensity Modulated Radiation Therapy (IMRT) | October 31, 2018
An analysis led by researchers at Philadelphia’s Fox Chase Cancer Center found treating localized prostate cancer with...
IBA Completes Installation of Two Proteus One Proton Therapy Systems in Japan
News | Proton Therapy | July 30, 2018
IBA (Ion Beam Applications S.A.) announced that they completed the first two installations of the Proteus One proton...
​ITN Celebrates World Cancer Day 2018
News | Radiation Oncology | February 01, 2018
World Cancer Day takes place annually on Feb.
UZ Leuven Treats First European Patient on Varian Halcyon Cancer Treatment System
News | Intensity Modulated Radiation Therapy (IMRT) | October 25, 2017
Varian recently announced an 80-year-old male with head and neck cancer became the first patient in Europe to be...
Varian Receives FDA 510k Clearance for Halcyon Treatment System
Technology | Intensity Modulated Radiation Therapy (IMRT) | July 05, 2017
Varian Medical Systems has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the Halcyon system,...
First New York Metropolitan Hospital Treats Cancer Patients With Accuray Radixact System
News | Image Guided Radiation Therapy (IGRT) | July 03, 2017
Accuray Inc. and Montefiore Einstein Center for Cancer Care (MECCC), part of the Montefiore Health System (MHS),...
IUCT Oncopole Installs First Radixact Radiotherapy System in France
News | Intensity Modulated Radiation Therapy (IMRT) | June 20, 2017
Accuray Inc. announced that the University Cancer Institute of Toulouse Oncopole (IUCT Oncopole) in Toulouse, France,...
cervical and endometrial cancer, IMRT, intensity modulated radiation therapy, side effects, ASTRO 2016 study
News | Intensity Modulated Radiation Therapy (IMRT) | September 29, 2016
Patients with cervical and endometrial cancer have fewer gastrointestinal and genitourinary side effects and experience...